BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Northwest Biotherapeutics, Inc. 

21720 23rd Drive SE, Suite 100

Bothell  Washington  98021  U.S.A.
Phone: 425-608-3000-or-877-606-9246-Toll-Free Fax: 425-608-3026


SEARCH JOBS


Industry
Services


Collaborations

Cytogen Corporation  Development of ex vivo prostate cancer immunotherapy





 Company News
Northwest Biotherapeutics (NWBT)'s Dr. Marnix Bosch to Present at Brain Tumor Biotech Summit in New York 6/6/2013 7:03:53 AM    More...
Northwest Biotherapeutics (NWBT) Added to the MSCI Global MicroCap Index 6/4/2013 8:44:32 AM    More...
Northwest Biotherapeutics (NWBT) to Present Company Highlights att the Marcum MicroCap Conference in New York 5/28/2013 7:22:08 AM    More...
Northwest Biotherapeutics (NWBT) Exhibit at the Upcoming American Society of Clinical Oncology Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 5/23/2013 7:16:29 AM    More...
Northwest Biotherapeutics (NWBT) Initiates Phase III DCVax®-L Brain Cancer Trial in Europe: King's College Hospital in the UK is First Site to Open 5/16/2013 10:36:54 AM    More...
Northwest Biotherapeutics (NWBT) Announces That Another Brain Cancer Patient From Phase I/II DCVax®-L Trials Has Surpassed Ten-Year Cancer-Free Survival 4/18/2013 9:59:47 AM    More...
Northwest Biotherapeutics (NWBT) Announces $10 Million Registered Direct Offering 4/18/2013 7:36:06 AM    More...
Northwest Biotherapeutics (NWBT)'s Phase III Trial With DCVax®-L for Brain Cancer "Adopted" as a National Priority Trial in UK 4/16/2013 10:34:46 AM    More...
Northwest Biotherapeutics (NWBT) 2012 Annual Report Shows Strong Progress and Enhancement of Leadership Position 4/9/2013 10:19:59 AM    More...
Northwest Biotherapeutics (NWBT) to Review Its Leadership Position in Immune Therapy at the 25th Annual Roth Conference 3/20/2013 8:43:23 AM    More...
12345678910...